LONDON BROKER RATINGS: RBC cuts Anglo American; Jefferies ups Berkeley
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:
Read moreThu, 15th Apr 2021 09:02
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:
Read more(Alliance News) - Stocks in London ended higher on Wednesday as investors continued to track the war in Ukraine, while in the US, Netflix weighed on the tech-heavy Nasdaq index.
Read more(Alliance News) - The FTSE 100 index moved upwards with a bit more conviction as the morning progressed in London on Wednesday, shaking off a mixed US earnings season.
Read more(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause.
Read more(Sharecast News) - Oxford Biomedica reported a 63% improvement in total revenues in its preliminary results on Wednesday, to £142.8m, although its outlook was somewhat less rosy amid a pause in vaccine manufacturing.
Read moreThursday 14 April | |
Ashmore Group PLC | Trading Statement |
Dunelm Group PLC | Trading Statement |
Hays PLC | Trading Statement |
Mediclinic International PLC | Trading Statement |
Ninety One PLC and Ltd | Trading Statement |
Norcros PLC | Trading Statement |
Friday 15 April | |
no events scheduled | |
Monday 18 April | |
no events scheduled | |
Tuesday 19 April | |
JTC PLC | Full Year Results |
Kainos Group PLC | Trading Statement |
Rio Tinto PLC | Q1 Production Results |
Wednesday 20 April | |
Bunzl PLC | Trading Statement |
Carr's Group PLC | Half Year Results |
Centamin PLC | Trading Statement |
Hunting PLC | Trading Statement |
IntegraFin Holdings PLC | Trading Statement |
John Wood Group PLC | Full Year Results |
Oxford Biomedica PLC | Full Year Results |
Petra Diamonds Ltd | Trading Statement |
Quilter PLC | Trading Statement |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
LONDON BROKER RATINGS: Imperials Brands raised; HSBC likes Fevertree
Read moreOxford Biomedica affirms end to licensing deal with Sio Gene Therapies
Read more(Sharecast News) - Oxford Biomedica's licensee for a Parkinson's disease treatment has pulled out of development and returned the rights to the UK company.
Read moreUPDATE: Oxford BioMedica raises GBP80 million via placing
Read moreLONDON MARKET CLOSE: Stocks close out rollercoaster week with losses
Read moreCORRECT: Oxford BioMedica to acquire 80% ownership of new US business
Read moreLONDON MARKET MIDDAY: Stocks sink on Ukraine tensions and hawkish Fed
Read moreOxford BioMedica to acquire 80% ownership of new US virus business
Read more(Sharecast News) - Cell and gene therapy specialist Oxford Biomedica announced an agreement with Homology Medicines on Friday, as well as a placing to raise £80m from new and existing shareholders, including a retail offer through the PrimaryBid platform.
Read more